Since its conception in 1951, the field of stereotactic radiosurgery (SRS) has demonstrated substantial growth, and it has altered treatment paradigms for patients with complex and diverse intracranial disorders.
12In the United States alone, there are more than 100 distinct SRS centers that treat thousands of patients each year. Patients are treated for diverse indications such as benign and malignant brain tumors, vascular malformations, and functional disorders.SRS is routinely delivered using several common radiosurgical devices. Despite the exponential growth of radiosurgery in the United States during the past 2 decades, the majority of the radiosurgical literature is composed of single-center retrospective studies.There are, of course, a small percentage of retrospective multicenter pooled analyses and even fewer prospective randomized clinical trials (RCTs). Some prospective multicenter SRS trials, such as ACOSOG-N0574 and the Stereotactic radiosurgery (SRS) represents a multidisciplinary approach to the delivery of ionizing high-dose radiation to treat a wide variety of disorders. Much of the radiosurgical literature is based upon retrospective single-center studies along with a few randomized controlled clinical trials. More timely and effective evidence is needed to enhance the consistency and quality of and clinical outcomes achieved with SRS. The authors summarize the creation and implementation of a national SRS registry. The American Association of Neurological Surgeons (AANS) through NeuroPoint Alliance, Inc., started a successful registry effort with its lumbar spine initiative. Following a similar approach, the AANS and NeuroPoint Alliance collaborated with corporate partners and the American Society for Radiation Oncology to devise a data dictionary for an SRS registry. Through administrative and financial support from professional societies and corporate partners, a framework for implementation of the registry was created. Initial plans were devised for a 3-year effort encompassing 30 high-volume SRS centers across the country. Device-specific web-based data-extraction platforms were built by the corporate partners. Data uploaders were then used to port the data to a common repository managed by Quintiles, a national and international health care trials company. Audits of the data for completeness and veracity will be undertaken by Quintiles to ensure data fidelity. Data governance and analysis are overseen by an SRS board comprising equal numbers of representatives from the AANS and NeuroPoint Alliance. Over time, quality outcome assessments and post hoc research can be performed to advance the field of SRS. Stereotactic radiosurgery offers a high-technology approach to treating complex intracranial disorders. Improvements in the consistency and quality of care delivered to patients who undergo SRS should be afforded by the national registry effort that is underway.